Field Trip Health Ltd Obtains Conditional Approval to List on Nasdaq Under the Symbol apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
TORONTO, June 03, 2021 Field Trip Health Ltd. , a leader in the development and delivery of psychedelic therapies, is pleased to announce that its common shares will commence trading on.
Message :
Required fields
.
TORONTO, March 17, 2021 (GLOBE NEWSWIRE) Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (
Field Trip ), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has closed the bought deal short form prospectus offering previously announced on February 25 and 26, 2021, including the full exercise of the underwriters’ over-allotment option (the
Offering ). In connection with the Offering, Field Trip issued 14,661,499 common shares, (“
Common Shares”) at a price of C$6.50 per Common Share, for aggregate gross proceeds of $95 million.
The lead investor in the Offering was Soleus Capital with additional participation by Avidity Partners, Sphera Funds, Pura Vida Investments, Jennison Associates and other healthcare specialized institutional investors.
Article content
Toronto-based Field Trip Health Ltd., has announced it has closed a common share deal worth $95 million.
The lead investor was Soleus Capital, a private equity firm based in Greenwich, Conn. Additionally, Avidity Partners, Sphera Funds, Pura Vida Investments, Jennison Associates and other healthcare-specialized institutional investors took part in the deal.
We apologize, but this video has failed to load.
Try refreshing your browser, or Field Trip Health announces closing of financing deal worth $95 million Back to video
“These are truly the pre-eminent biotech and pharma investors out there,” Ronan Levy, co-founder and executive chairman of Field Trip Health, told